MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.

Abstract MS-377 ((R)-(+)-1-(4-chlorophenyl)-3-[4-(2-methoxyethyl)piperazin-1-yl]methyl-2-pyrrolidinone L-tartrate) is a antipsychotic agent that binds to sigma-1 receptor. MS-377 showed anti-dopaminergic and anti-serotonergic activities and antagonistic action against phencyclidine (PCP)-induced behaviors in an animal model. These anti-psychotic activities of MS-377 are attributable to association with sigma-1 receptor. However, the mechanism by which the sigma-1 receptor ligands exact those numerous effects remains to be elucidated. In the present study, we evaluated the effect of MS-377 on N-methyl-D-aspartate (NMDA) receptor ion-channel complex in primary cultured rat neuronal cells. First, we examined the effect of MS-377 on NMDA-induced Ca 2+ influx with fura-2/AM loaded cells. MS-377 showed no effects on the basal Ca 2+ concentration and NMDA-induced Ca 2+ influx by itself. PCP and SKF-10047 reduced the NMDA-induced increase in intracellular Ca 2+ concentration. Pre-incubation of 1 μM MS-377 was found to significantly block the reduction by PCP or SKF-10047 of the NMDA-induced Ca 2+ influx. Second, the effect of MS-377 on [ 3 H]MK-801 intact cell binding was examined. PCP, haloperidol and (+)-pentazocine inhibited [ 3 H]MK-801 binding, although MS-377 showed no effect by itself. Pre-treatment of MS-377 markedly reversed the inhibition of [ 3 H]MK-801 binding by PCP in a dose-dependent manner. These effects of MS-377 may depend on its affinity for the sigma-1 receptor, because MS-377 is a selective sigma-1 receptor ligand without any affinity for NMDA receptor ion-channel complex. These observations suggest that the MS-377 indirectly modulated the NMDA receptor ion-channel complex, and the anti-psychotic activities of MS-377, in part, are attributable to such on action via sigma-1 receptor.